Literature DB >> 18752142

Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.

K E Berge1, K H Haugaa, A Früh, O-G Anfinsen, K Gjesdal, G Siem, N Oyen, G Greve, A Carlsson, T O Rognum, M Hallerud, E Kongsgård, J P Amlie, T P Leren.   

Abstract

Mutations in the KCNQ1, HERG, SCN5A, minK and MiRP1 genes cause long QT syndrome (LQTS), of which there are two forms: the Romano Ward syndrome and the Jervell and Lange-Nielsen syndrome. We have performed DNA sequencing of the LQTS-associated genes in 169 unrelated patients referred for genetic testing with respect to Romano Ward syndrome and in 13 unrelated patients referred for genetic testing with respect to Jervell and Lange-Nielsen syndrome. A total of 37 different mutations in the 5 genes, of which 20 were novel, were identified. Among patients with the most stringent clinical criteria of Romano Ward syndrome, a mutation was identified in 71%. Twelve of the 13 unrelated patients referred for genetic testing with respect to Jervell and Lange-Nielsen syndrome were provided with a molecular genetic diagnosis. Cascade genetic screening of 505 relatives of index patients with molecularly defined LQTS identified 251 mutation carriers. The observed penetrance was 41%. Although caution must be exerted, the prevalence of heterozygotes for mutations in the LQTS-associated genes in Norway could be in the range 1/100-1/300, based on the prevalence of patients with Jervell and Lange-Nielsen syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752142     DOI: 10.1080/00365510701765643

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  26 in total

1.  Long QT syndrome KCNH2 mutation with sequential fetal and maternal sudden death.

Authors:  Jon M Tuveng; Britt-Marie Berling; Gabor Bunford; Carlos G Vanoye; Richard C Welch; Trond P Leren; Alfred L George; Torleiv Ole Rognum
Journal:  Forensic Sci Med Pathol       Date:  2018-06-08       Impact factor: 2.007

Review 2.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Deep Mutational Scan of an SCN5A Voltage Sensor.

Authors:  Andrew M Glazer; Brett M Kroncke; Kenneth A Matreyek; Tao Yang; Yuko Wada; Tiffany Shields; Joe-Elie Salem; Douglas M Fowler; Dan M Roden
Journal:  Circ Genom Precis Med       Date:  2020-01-12

Review 4.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Transl Res       Date:  2012-09-17       Impact factor: 7.012

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases.

Authors:  M K Larsen; K E Berge; T P Leren; P H Nissen; J Hansen; I B Kristensen; J Banner; H K Jensen
Journal:  Int J Legal Med       Date:  2012-01-06       Impact factor: 2.686

7.  Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases.

Authors:  C L Hertz; S L Christiansen; L Ferrero-Miliani; S L Fordyce; M Dahl; A G Holst; G L Ottesen; R Frank-Hansen; H Bundgaard; N Morling
Journal:  Int J Legal Med       Date:  2014-12-03       Impact factor: 2.686

8.  Drosophila ryanodine receptors mediate general anesthesia by halothane.

Authors:  Shuying Gao; David J Sandstrom; Harold E Smith; Brigit High; Jon W Marsh; Howard A Nash
Journal:  Anesthesiology       Date:  2013-03       Impact factor: 7.892

9.  The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

Authors:  Argelia Medeiros-Domingo; Zahurul A Bhuiyan; David J Tester; Nynke Hofman; Hennie Bikker; J Peter van Tintelen; Marcel M A M Mannens; Arthur A M Wilde; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

10.  Asymmetry of parental origin in long QT syndrome: preferential maternal transmission of KCNQ1 variants linked to channel dysfunction.

Authors:  Hideki Itoh; Myriam Berthet; Véronique Fressart; Isabelle Denjoy; Svetlana Maugenre; Didier Klug; Yuka Mizusawa; Takeru Makiyama; Nynke Hofman; Birgit Stallmeyer; Sven Zumhagen; Wataru Shimizu; Arthur A M Wilde; Eric Schulze-Bahr; Minoru Horie; Sophie Tezenas du Montcel; Pascale Guicheney
Journal:  Eur J Hum Genet       Date:  2015-12-16       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.